Identification |
Name: | Morphinan-3,14-diol,17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5a)- |
Synonyms: | (-)-Nalmefene;6-Deoxo-6-methylenenaltrexone; 6-Desoxy-6-methylenenaltrexone; JF 1; Nalmefene;Nalmetrene; ORF 11676 |
CAS: | 55096-26-9 |
Molecular Formula: | C21H25 N O3 |
Molecular Weight: | 339.43 |
InChI: | InChI=1/C21H26NO3/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13/h4-5,13,16,19,21,23-24H,1-3,6-11H2/t16?,19-,20-/m0/s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 188 - 190 |
Stability: | No data. |
Solubility: | Insoluble |
Specification: |
Nalmefene (CAS No.55096-26-9), its synonyms are (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinon-3,14-diol ;17-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-
3,14-diol ;6-Desoxy-6-methylenenaltrexone ; 9a-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylen-3,14-morphinandiol .
|
Storage Temperature: | 2-8°C |
Color: | Crystals from ethyl acetate |
Usage: | Medication. |
Safety Data |
|
|